Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials Sponsored by Dr. Prof. M.P. Laguna Pes
Total 1 results
Dr. Prof. M.P. Laguna Pes
Angiodynamics, Inc.
Unknown
Safety and Feasibility of IRE for SRMs
Kidney Cancer
Netherlands
Sponsors and Collaborators
Cardresearch
San MediTech(Huzhou)Co.,Ltd.
Societa Italiana di Endoscopia Digestiva
CRMBM-CEMEREM
ProteoSys AG
Caritas Freetown
University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
Fondren Orthopedic Group L.L.P.
Celtaxsys Aus Pty Limited
Victor Montori
Alberta Children's Hospital, Calgary, Canada
Elim Pediatric Pharmaceuticals Inc.
University Medical Center Goettingen
Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
Donders Institute for Brain, Cognition and Behavior
Rui-hua Xu, MD, PhD
Diego Hernan Giunta, MD
AMTC & Associates
Norsk Proteinintolerance, Norway
The Fifth Affiliated Hospital of Zunyi Medical College
View Full List
Medical Conditions
Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
Fever, Sweats, and Hot Flashes
Malignant Ascites Due to Epithelial Carcinoma
Postcomatose Unawareness State
Atrial Fibrillation, Postoperative
Normal Diameter of Optic Nerve
Disturbance of Activity and Attention
Auditory Hallucination, Verbal
Non-dystrophic Myotonias
Lymphedema of Arm
Spermatogenesis Arrest
Tube Disorders Eustachian
Fibromyalgia Syndrome, Primary
Stereotactic Radioablation for Ventricular Tachycardia
Gynecologic Cancer
Tularaemia
Non-compressible Torso Hemorrhage
Plasmodium Falciparum Malaria (Drug Resistant)
Prostate Cancer Recurrent
Orbital Tumor
View Full List
Drug Interventions
Enzalutamide, Abiraterone
Atezolizumab
Mupirocin Calcium
Topotecan
Cetrorelix 78 mg + 78 mg
HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
PF-00868554
Polyethylene glycol 3350
CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
Lamivudine
Ruxolitinib
Oxycodone, fentanyl
Indoximod
Insulin
SERETIDE Diskus
Epimedium Prenylflavonoids Extract
Cytarabine ARA-C
Flibanserin 100 mg dose every evening
Methotrexate
Bortezomib/dexamethasone
View Full List
CROs by country
Contract Research Organizations in Bahrain
Contract Research Organizations in Belgium
Contract Research Organizations in Equatorial Guinea
Contract Research Organizations in Ghana
Contract Research Organizations in Guinea
Contract Research Organizations in Indonesia
Contract Research Organizations in Japan
Contract Research Organizations in Kyrgyzstan
Contract Research Organizations in Madagascar
Contract Research Organizations in Mauritania
Contract Research Organizations in Oman
Contract Research Organizations in Togo
Contract Research Organizations in Turkmenistan
CRO list by country
CROs in Ghana
ACROSS Global
SGS
54gene’s Clinical Programs Group (CPG)
All CROs in Ghana
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe